Back to Search
Start Over
Blood Lymphocyte Subsets and Proinflammatory Cytokine Profile in ROHHAD(NET) and non-ROHHAD(NET) Obese Individuals.
- Source :
- Journal of the Endocrine Society; Sep2023, Vol. 7 Issue 9, p1-12, 12p
- Publication Year :
- 2023
-
Abstract
- Context Rapid-onset obesity with central hypoventilation, hypothalamic dysfunction, and autonomic dysregulation with neural crest tumors (ROHHAD-NET) syndrome pathophysiology remains elusive. Acquired neuroimmunological dysfunction has been proposed as a possible pathogenetic pathway. Objective The aim of our study was to characterize lymphocyte subpopulations subsets in peripheral blood (PB) and to evaluate a panel of proinflammatory cytokines/chemokines in ROHHAD(NET) patients vs controls. Methods We included 11 ROHHAD(NET) patients, 7 ROHHAD and 4 ROHHAD-NET, selected by clinical criteria. Controls were 11 simple obese children, matched for age and sex. Flow cytometric analysis and enzyme-linked immunosorbent assay were performed on PB and serum samples of the 2 groups. Results Analysis revealed that T lymphocytes are significantly increased in ROHHAD(NET) patients (P =.04) with a prevalence of CD4-T cells (P =.03) and a lower number of activated CD8-T cells (P =.02). With regard to regulatory subset, patients displayed increased regulatory B cells (P =.05) and type-1 regulatory T cells (P =.03). With regard to CD8-T cells, a lower number of T effector memory was observed (P =.02). In contrast, among CD4-T cells, we found a higher number of T naive (P =.04) and T effector (P =.0008). Interleukin-8 (IL-8) levels and monocyte chemotactic protein-1 were increased in patients vs controls (P =.008 and P =.01, respectively). Furthermore, IL-8 levels were higher in the subgroup with neural tumor (P =.0058) (ROHHAD-NET) than in patients without neural tumor (ROHHAD). Soluble HLA-G was significantly lower in patients vs controls (P =.03). Conclusion Our findings contribute to support the hypothesis of immune dysregulation, which may underlie this complex, often fatal disease. Because ROHHAD(NET) syndrome is an ultra-rare disease, multicentric studies are needed to improve the effect of our data in the management of this condition. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 24721972
- Volume :
- 7
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Journal of the Endocrine Society
- Publication Type :
- Academic Journal
- Accession number :
- 170902998
- Full Text :
- https://doi.org/10.1210/jendso/bvad103